Jeffrey Bode

Jeffrey studied chemistry and philosophy at Trinity University in San Antonio, Texas, where he worked in the research group of external pageProf. Michael P. Doylecall_made. After PhD studies at the the California Institute of Technology and ETH Zürich with Prof. Erick M. Carreira, he spent two years in Japan as a JSPS postdoctoral fellow with external pageProf. Keisuke Suzukicall_made at the Tokyo Institute of Technology. In 2003, he began his independent career in US, at UC-Santa Barbara and then the University of Pennsylvania. In 2010, he moved to the Swiss Federal Institute of Technology (ETH) in Zürich, Switzerland, as a full Professor in the Laboratory of Organic Chemistry. Since 2013, he is also a Principal Investigator at the external pageInstitute of Transformative bio-Moleculescall_made at Nagoya University, where the Bode Group has a satellite laboratory.

Since starting his academic career, Jeffrey's research and teaching have been recognized by numerous awards including an Arthur C. Cope Scholar Award (2008), and and Elias J. Corey Award for Outstanding Original Contribution in Organic Synthesis by a Young Investigator (2011). His research group founded and operates the “Make-a-Molecule” outreach program for young scientist. He has served as Chair of the Editorial Board for Organic and Biomolecular Chemistry (2011–2014), as Co-Editor-in-Chief of Helvetica Chimica Acta, and is currently an Executive Editor for Encyclopedia of Reagents for Organic Synthesis. Research in his group has led to the formation of two companies, Synple Chem AG (Zürich, CH) for the automation of organic synthesis and Bright Peak Therapeutics (Basel and San Diego) for next generation therapeutic proteins. He currently serves on the Division II Research Council for the Swiss National Science Foundation and as Director of Studies for the new Biochemistry and Chemical Biology Curriculum at ETH Zürich.